Researchers
Scientific Liaison
Manuel López-Figueroa, Ph.D., is the Scientific Liaison for the Pritzker Neuropsychiatric Disorders Research Consortium. Dr. López is responsible for planning and directing all aspects of the consortium including strategy, R&D, legal (IP & contracts) and financial, to facilitate the commercialization of discoveries to fund additional research. Dr. López is also a Vice President at Bay City Capital and has been with the firm since July 2001. Bay City Capital was established in 1997 for the purpose of managing investment funds in the life sciences industry. The company manages seven venture funds representing $1.6 billion in capital invested in over 85 companies. Dr. López specializes in evaluating investment opportunities with an emphasis on CNS. Dr. López has over 15 years of experience in the field of Neuroscience, has won numerous awards during his academic research career, and has published extensively. He completed post-doctoral work at the University of Michigan and at the University of Copenhagen, Denmark. Dr. López received a PhD in Medicine and Surgery, and a MS in Molecular and Cell Biology from the Universities of Las Palmas and La Laguna, Spain, respectively.
Scientific Coordinator
Cortney A. Turner, Ph.D. is the Scientific Coordinator for the Pritzker Neuropsychiatric Disorders Research Consortium. Dr. Turner received her B.S. from Bowling Green State University in psychology and biology. She received her Ph.D. from the University of Florida in Medical Sciences with a concentration in Neuroscience. She completed her postdoctoral training at the University of Michigan. Currently, she is a research investigator at the University of Michigan. She is a member of Phi Beta Kappa and has received the Rachel Upjohn Clinical Scholars Award in Psychiatry for her research. Dr. Turner facilitates scientific discourse between members to achieve the goals of the consortium. She also assists with data organization and management for the group using a web based query system.
Principal Investigators
Animal Models
Dr. Francis Lee
molecular and neural mechanisms relevant to neuropsychiatic disorders using genetic models focused on growth factors.
Dr. David Lyons
primate neuroendocrinology and genetics of stress coping
Dr. Paresh Patel
psychiatrist, gene expression in depression
Dr. Audrey Seasholtz
mouse models of psychiatric disease
Bioinformatics
Dr. Fan Meng
bioinformatician
Clinical Samples
Dr. Margaret Altemus
psychiatrist, psychiatric conditions and hormonal disorders
Dr. Blynn Bunney
circadian rhythms in psychiatric disorders
Dr. Richard Friedman
psychiatrist, psychotherapy
Dr. Bruno Giordani
psychiatrist, cognitive neuropsychological assessments in psychiatric disorders
Dr. James Kocsis
Psychopathology, psychophysiology and genetics of affective and anxiety disorders. The treatment of depression in co-morbid conditions, such as substance abuse and epilepsy.
Dr. Juan López
psychiatrist, neuroendocrinology and depression
Dr. Melvin McInnis
psychiatrist, genetics of bipolar disorder
Dr. Richard Stein
effects of smoking status on genomic expression in the human brain
Dr. David Walsh
clinical psychologist
Dr. Barnett Meyers
phenomenology and predictors of treatment response in psychotic depression
Genetics
Dr. Devin Absher
analysis of genetic variants in human diseases
Dr. Michael Boehnke
human gene mapping, genome-wide association studies and next generation sequencing based association studies, type 2 diabetes, bipolar disorder
Dr. Margit Burmeister
human geneticist, genetic variations in mood disorders
Dr. Charles E. Glatt
the role of genetic variation in the regulation of human emotions: using animal models to understand function
Dr. Jun Li
statistical geneticist, analysis of gene expression datasets
Dr. Geoffrey Murphy
application of genetic techniques to mouse models
Dr. Laura Scott
statistical geneticist, bipolar disorder
Dr. Robert Thompson
microRNAs to assess psychiatric disorders
Dr. Michael Uhler
genetic mouse models and techniques
Dr. Marquis Vawter
genetic analyses in human psychiatric disorders, cell lines
Neuroimaging
Dr. Terence Ketter
Understanding the etiology, phenomenology and treatment of Bipolar Disorder with a focus on brain imaging techniques, the development and course of the disorder and clinical trials.
Dr. Fabio Macciardi
clinical neuroimaging in psychiatric disorders
Dr. Jon-Kar Zubieta
genetic factors and functional brain measures that underlie subtypes and treatment response in mood disorders
Dr. BJ Casey
To identify mechanisms of resilience and vulnerability across development using neuroimaging and genetic approaches.
Researchers
Anatomy
Dr. David Krolewski
hypothalamic neuroanatomy, lipid metabolism in mood disorders
Dr. Adriana Medina
hypothalamic and hippocampal neuroanatomy in mood disorders
Dr. Vikram Sharma
amygdala neuroanatomy in mood disorders
Dr. Maria Waselus
anatomy, neurogenesis and synaptic plasticity in drug abuse
Animal Models
Dr. Peter Blandino
stress-related and immune system gene expression interactions in mood disorders
Dr. Claudio Caamaño
protein biochemist, novel therapeutic targets
Dr. Shelly Flagel
individual differences in vulnerability to addiction
Dr. Cortney Turner
behavioral pharmacology, animal models of mood disorders
Bioinformatics
Manhong Dai
bioinformatician
Andy Lin
bioinformatician
Clinical Samples
Dr. Preston Cartagena
clinical psychologist
Dr. Maureen Martin
clinical psychologist
Dr. Julie Patterson
clinical psychologist
Genetics
Dr. Kevin Bowling
methylation and RNA sequencing of human tissues and diseases
Dr. Adolfo Sequeira
genetic analysis of suicide
Support Staff
Hseinyuan Grace Chang
database management
Jennifer Fitzpatrick
research technician
Linda Gates
research technician
Hui Li
research technician
Linda Morgan
research technician
Virginia Weinberg
clinical study coordinator and nurse
